news
Oramed appoints Dr Simon Bruce as Vice President of Medical Affairs
Oramed announced today the appointment of Dr Simon Bruce MD to the newly created position of Vice President of Medical Affairs...
List view / Grid view
Appointments
news
Steven Baertschi joins EPR advisory board
Dr Steven Baertschi has joined the editorial advisory board of European Pharmaceutical Review.
news
Ashfield appoints new regional presidents in US and Japan
Ashfield welcomes Greg Flynn to the US and Mick O’Leary to Japan…
news
Dr Vasant Narasimhan elected a member of the US National Academy of Medicine
11 November 2015 | By Victoria White
The US National Academy of Medicine (NAM) recently announced the election of Dr Vasant “Vas” Narasimhan as a member of the Academy.
news
Giovanni Caforio, M.D., appointed Chief Operating Officer and elected to Board of Directors
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb’s Board of Directors, effective June 5, 2014. He will continue to report to Lamberto Andreotti, chief executive officer. In addition to his current responsibilities as chief commercial officer, Caforio…
news
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
"Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience..."
news
Roger M. Perlmutter appointed as President of Merck Research Laboratories
7 March 2013 | By Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role…
news
Jean-Marc Pardonge appointed as new President of Aptar Pharma Prescription Division
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.
news
Pascal Soriot appointed Chief Executive Officer of AstraZeneca
AstraZeneca today announced that Pascal Soriot has been appointed as the company’s Chief Executive Officer. Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012.
news
Biomarker specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman
27 March 2012 | By College Hill
Activiomics Limited., the developer of innovative biomarker technologies has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
news
Stuart Grant appointed Patheon’s Executive Vice President, Chief Financial Officer
Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Stuart Grant has been appointed Patheon's Executive Vice President, Chief Financial Officer. Mr. Grant comes to Patheon following an accomplished career with increasing levels of responsibility in finance for several…
news
Antonella Mancuso appointed Patheon’s President, Global Commercial Operations and Chief Manufacturing Officer
Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Antonella Mancuso has been promoted to President, Global Commercial Operations and Chief Manufacturing Officer, responsible for Patheon's global commercial manufacturing operations . Ms. Mancuso will assume responsibility for all of…
news
Richard Daniell appointed as Managing Director of Teva UK Limited
Teva UK Limited has announced that Richard Daniell has been appointed as Managing Director, responsible for all Teva’s commercial activities in the UK.
news
Anirvan Ghosh named Head of Discovery for Roche’s CNS
21 February 2011 | By Roche
Role will focus on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression & neurodevelopment...
news
Clondalkin Group appoints Peach to support pharma growth
14 February 2011 | By Adessi
Clondalkin Group has appointed Paul Peach to support its growth strategy within pharmaceuticals and healthcare...
